PPARA and inherited lipid metabolism disorder: These differences might explain why long-term treatment with PPARα ligands have been shown to induce carcinogenesis in rodents but carcinogenesis has not been observed in humans treated with the PPARα agonists fibrates for dyslipidaemia over the decades [89].